Related Experiment Video
Updated: Jun 4, 2025

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer
Published on: September 18, 2020
Oral Microbiome Signatures as Potential Biomarkers for Gastric Cancer Risk Assessment
Haejin In1, Shruthi R Perati2, Mykhaylo Usyk3
1Division of Surgical Oncology, Rutgers Cancer Institute, New Brunswick, NJ; Department of Surgery, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ.
Oral microbiome analysis reveals distinct bacterial signatures in individuals with gastric cancer (GC) and premalignant gastric conditions (Pre-GC). These oral microbial profiles can help differentiate between healthy individuals and those at risk for GC.
Area of Science:
- Microbiome research
- Cancer diagnostics
- Oral health
Background:
- Gastric cancer (GC) is a significant global health concern, ranking as the fifth leading cause of cancer-related mortality.
- Investigating the oral microbiota offers a potential avenue for distinguishing between GC, premalignant gastric conditions (Pre-GC), and healthy controls.
Purpose of the Study:
- To analyze the oral microbiome's biodiversity and composition in GC, Pre-GC, and control participants.
- To identify specific oral microbial signatures that can discriminate between these groups.
- To evaluate the diagnostic potential of oral microbiome profiles for GC risk prediction.
Main Methods:
- Prospective collection of mouthwash samples from 98 participants (30 GC, 30 Pre-GC, 38 controls).
- DNA extraction, sequencing, and comprehensive analyses of oral microbiome biodiversity and composition.
- Utilized receiver operating characteristic (ROC) curves to assess the discriminative power of identified microbial signatures.
Main Results:
- Significant differences in oral microbiome beta diversity were observed between GC and control groups (p<0.02).
- 32 bacterial genera were differentially abundant in GC vs. controls, and 23 in Pre-GC vs. controls.
- Models based on key bacterial signatures accurately discriminated between GC and controls (AUC=0.880) and Pre-GC and controls (AUC=0.943).
Conclusions:
- Oral microbiome profiles in GC and Pre-GC participants are distinct from controls, though similar to each other.
- These distinct oral microbial signatures hold promise for the non-invasive prediction of gastric cancer risk.
Related Concept Videos
What is Monogastric Digestion?
Serum Laboratory Studies, Stool Test, Breath Test
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.

